| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/06/1997 | WO1997003951A1 Esters and amides as pla2 inhibitors |
| 02/06/1997 | WO1997003944A1 Aliphatic tricarboxylic acid compounds and their production process |
| 02/06/1997 | WO1997003783A1 Metalloproteinase inhibitors |
| 02/06/1997 | WO1997003709A1 Agent, for transdermal application, containing esters of 3-ketodesogestrel |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003701A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | WO1997003699A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 02/06/1997 | WO1997003698A1 Hormone patch |
| 02/06/1997 | WO1997003696A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1997003686A1 Tnf receptor and steroid hormone in a combined therapy |
| 02/06/1997 | WO1997003684A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 02/06/1997 | WO1997003682A1 Method for treating cancers using 6-[3-[1-adamantyl]-4-hydroxyphenyl] |
| 02/06/1997 | WO1997003681A1 Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene |
| 02/06/1997 | WO1997003680A1 Transferrin glycans composition for the induction of immune tolerance |
| 02/06/1997 | WO1997003679A1 Phosphorous-containing cysteine and serine protease inhibitors |
| 02/06/1997 | WO1997003678A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/06/1997 | WO1997003677A1 Inhibition of nmda receptor activity by pregnenolone sulfate derivatives |
| 02/06/1997 | WO1997003676A1 Novel pharmaceutical formulation of dehydroepiandrosterone for percutaneous topical application |
| 02/06/1997 | WO1997003675A1 Use of cgmp-phosphodiesterase inhibitors to treat impotence |
| 02/06/1997 | WO1997003674A1 Bioprotectant composition, method of use and extraction process of curcuminoids |
| 02/06/1997 | WO1997003673A1 Sustained-release formulation of d-threo-methylphenidate |
| 02/06/1997 | WO1997003672A1 THERAPEUTIC USE OF d-threo-METHYLPHENIDATE |
| 02/06/1997 | WO1997003671A1 Composition comprising d-threo-methylphenidate and another drug |
| 02/06/1997 | WO1997003670A1 Paroxetine controlled release compositions |
| 02/06/1997 | WO1997003669A1 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls |
| 02/06/1997 | WO1997003668A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 02/06/1997 | WO1997003667A1 Method of treating colonic adenomas |
| 02/06/1997 | WO1997003666A1 Agent for suppressing tumour growth |
| 02/06/1997 | WO1997003665A1 Treatment of attention-deficit/hyperactivity disorder |
| 02/06/1997 | WO1997003664A1 Use of ipriflavone to reduce the number of cd8+ cells |
| 02/06/1997 | WO1997003663A1 NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF |
| 02/06/1997 | WO1997003662A1 Pharmaceutical composition of l-dopa ethyl ester |
| 02/06/1997 | WO1997003661A1 Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells |
| 02/06/1997 | WO1997003660A2 Modulation of protein phosphatase activity and uses relating to fertility and contraception |
| 02/06/1997 | WO1997003659A1 Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis |
| 02/06/1997 | WO1997003655A1 Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules |
| 02/06/1997 | WO1997003654A2 Pharmaceutical compositions |
| 02/06/1997 | WO1997003650A1 Ionophore antibiotic formulations |
| 02/06/1997 | WO1997003648A1 Compositions for topical delivery of active ingredients |
| 02/06/1997 | WO1997003647A1 Topical compositions having improved skin feel |
| 02/06/1997 | WO1997003629A1 Drug delivery compositions for improved stability of steroids |
| 02/06/1997 | WO1996040042A3 Stabilized steroid compositions |
| 02/06/1997 | WO1996037210A3 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
| 02/06/1997 | WO1996036324A3 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions |
| 02/06/1997 | WO1996036314A3 Method for drug delivery to the pulmonary system |
| 02/06/1997 | WO1996035415A3 Use of sesquiterpenes for inhibiting oxidative enzymes |
| 02/06/1997 | WO1996031475A3 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors |
| 02/06/1997 | WO1996029068A3 Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this |
| 02/06/1997 | WO1996013512A3 L-ribofuranosyl nucleosides |
| 02/06/1997 | DE19528524A1 Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung Calcium-containing phosphate binding agents for intestinal and process for its preparation |
| 02/06/1997 | DE19528145A1 Neue Arzneimittel und ihre Verwendung New drugs and their use |
| 02/06/1997 | CA2230036A1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii |
| 02/06/1997 | CA2227956A1 Compositions for topical delivery of active ingredients |
| 02/06/1997 | CA2227634A1 Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells |
| 02/06/1997 | CA2227592A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | CA2227538A1 Hormone patch |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2227466A1 Esters and amides as pla2 inhibitors |
| 02/06/1997 | CA2227442A1 4,5-diaryl oxazole derivatives |
| 02/06/1997 | CA2227441A1 Hepadvavirus receptor |
| 02/06/1997 | CA2227421A1 Use of ipriflavone to reduce the number of cd8+ cells |
| 02/06/1997 | CA2227410A1 Treatment of attention-deficit/hyperactivity disorder |
| 02/06/1997 | CA2227370A1 Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | CA2227208A1 Pharmaceutical composition of l-dopa ethyl ester |
| 02/06/1997 | CA2227198A1 Cysteine protease inhibitors for use in treatment of ige mediated allergic diseases |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2227035A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | CA2227034A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/06/1997 | CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins |
| 02/06/1997 | CA2227013A1 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | CA2226879A1 Transferrin glycans composition for the induction of immune tolerance |
| 02/06/1997 | CA2226872A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | CA2226871A1 Non-.beta.-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof |
| 02/06/1997 | CA2226761A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 02/06/1997 | CA2226414A1 Phosphorous-containing cysteine and serine protease inhibitors |
| 02/06/1997 | CA2223914A1 Compositions and methods for catalyzing hydrolysis of hiv gp120 |
| 02/06/1997 | CA2223646A1 Novel heterocyclic compounds for the treatment of pain and use thereof |
| 02/06/1997 | CA2223644A1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists |
| 02/06/1997 | CA2223629A1 Therapeutic use of d-threo-methylphenidate |
| 02/06/1997 | CA2223489A1 Method for treating cancer using ahpn |
| 02/06/1997 | CA2219501A1 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls |
| 02/06/1997 | CA2199635A1 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 02/06/1997 | CA2199273A1 Epimers of (22rs)-n-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5.alpha.-androst-1-ene-17.beta.-carboxamide |
| 02/05/1997 | EP0757058A1 Cyclic peptide anti-fungal agents |
| 02/05/1997 | EP0757057A2 Process for crystallisation of macromolecules |
| 02/05/1997 | EP0757056A1 Method for preparing 1-beta-D-arabinofuranosylcytosine |
| 02/05/1997 | EP0757055A2 Glycosides, sugar-free degradation products and derivatives of the same |
| 02/05/1997 | EP0757050A1 Antibacterial penem esters derivatives |
| 02/05/1997 | EP0757049A1 Camptothecin derivatives |
| 02/05/1997 | EP0757039A1 Endothelin receptor antagonists |
| 02/05/1997 | EP0756870A2 Pharmaceutical compositions for topic use on the basis of ketoprofen |
| 02/05/1997 | EP0756869A2 Use of duloxetine or of N-alkyl-3-phenyl-(2-alkylthiophenoxy)-propylamines for treating attention-deficit/hyperactivity disorder |
| 02/05/1997 | EP0756868A2 Aerosol compositions |
| 02/05/1997 | EP0756862A1 Use of bradykinine antagonist in a cosmetic, pharmaceutical or dermatological composition and the composition obtained |
| 02/05/1997 | EP0756827A2 Composition for nutrition |
| 02/05/1997 | EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |